Glaxo, Sanofi near £500M COVID-19 vaccine deal with the U.K.

Jul. 05, 2020 4:06 AM ETSanofi (SNY), GSKGSK, SNYBy: Yoel Minkoff, SA News Editor18 Comments

Sanofi (NASDAQ:SNY) and GlaxoSmithKline (NYSE:GSK) are close to a £500M deal to supply the British government with 60M doses of their coronavirus vaccine, according to the Sunday Times.
The business department is understood to be taking an option to buy the vaccine from the pharma giants should it work in human trials, which are due to begin in September.